Silva Pharmaceuticals Limited (DSE:SILVAPHL)
Bangladesh · Delayed Price · Currency is BDT 13.50
-0.20 (-1.46%)
At close: Sep 3, 2026
Silva Pharmaceuticals Market Cap
Silva Pharmaceuticals has a market cap or net worth of 1.84 billion as of September 4, 2026. Its market cap has increased by 4.65% in one year.
Market Cap
1.84B
Enterprise Value
1.76B
Revenue
329.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
13.50
ChartMarket Cap Chart
Since October 10, 2018, Silva Pharmaceuticals's market cap has decreased from 3.77B to 1.84B, a decrease of -51.12%. That is a compound annual growth rate of -8.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 1.84B | 43.62% |
| Dec 30, 2025 | 1.28B | -7.84% |
| Dec 30, 2024 | 1.39B | -52.78% |
| Dec 28, 2023 | 2.95B | - |
| Dec 29, 2022 | 2.95B | 20.67% |
| Dec 30, 2021 | 2.44B | -2.19% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| The IBN SINA Pharmaceutical Industry | 9.84B |
| Navana Pharmaceuticals | 7.26B |
| Orion Pharma | 6.18B |
| Techno Drugs | 5.87B |
| Indo-Bangla Pharmaceuticals | 2.03B |
| Silco Pharmaceuticals | 1.85B |
| Pharma Aids | 1.80B |
| Ambee Pharmaceuticals | 1.79B |